Search Results 861-870 of 18263 for Lactation
* Lactating females are not eligible unless they have agreed not to breastfeed their infants starting with the first dose of study therapy through 5 months ...
- Females who are pregnant or lactating. The participant has previously received treatment with any CDK4 and CDK6 inhibitor. The participant is receiving ...
Subject is pregnant or lactating, or plans to become pregnant within the study timeframe. Subject has an inability to tolerate bronchoscopy under moderate ...
... lactating; Other concomitant disease, malignancy, or condition likely to significantly decrease life expectancy to less than the duration of the trial (e.g. ...
Pregnant or lactating female. Female planning to become pregnant or planning to discontinue contraceptive precautions (if of childbearing potential) before ...
Pregnant or lactating women or women of childbearing potential who do not employ a reliable method of contraception as judged by the Investigator, and/or ...
* Participant is pregnant or lactating or intends to become pregnant during the study. * Participant has severe renal impairment . * Participant is ...
Pregnant or lactating women; Positive serum human chorionic gonadotropin (hCG) measured prior to the first obinutuzumab infusion; Primary or secondary ...
Women who are lactating, pregnant, or intend to become pregnant during the course of the study; Patients who are investigational site staff members and their ...
... lactating at time of enrollment. Note: Other protocol defined Inclusion/Exclusion Criteria may apply. Eligibility last updated 4/14/2025. Questions regarding ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.